97 related articles for article (PubMed ID: 11851326)
1. Synthetic peptides as functional mimics of a viral discontinuous antigenic site.
Villén J; Borràs E; Schaaper WM; Meloen RH; Dávila M; Domingo E; Giralt E; Andreu D
Biologicals; 2001; 29(3-4):265-9. PubMed ID: 11851326
[TBL] [Abstract][Full Text] [Related]
2. Functional mimicry of a discontinuous antigenic site by a designed synthetic peptide.
Villén J; Borràs E; Schaaper WM; Meloen RH; Dávila M; Domingo E; Giralt E; Andreu D
Chembiochem; 2002 Mar; 3(2-3):175-82. PubMed ID: 11921395
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the immune response against mixotope peptide libraries from a main antigenic site of foot-and-mouth disease virus.
Oliveira Ed; Jiménez-Clavero MA; Núñez JI; Sobrino F; Andreu D
Vaccine; 2005 Apr; 23(20):2647-57. PubMed ID: 15780448
[TBL] [Abstract][Full Text] [Related]
4. Towards a multi-site synthetic vaccine to foot-and-mouth disease: addition of discontinuous site peptide mimic increases the neutralization response in immunized animals.
Villén J; de Oliveira E; Núñez JI; Molina N; Sobrino F; Andreu D
Vaccine; 2004 Sep; 22(27-28):3523-9. PubMed ID: 15315831
[TBL] [Abstract][Full Text] [Related]
5. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
[TBL] [Abstract][Full Text] [Related]
6. Expression of a foot-and-mouth disease virus immunodominant epitope by a filamentous bacteriophage vector.
Kim YJ; Lebreton F; Kaiser C; Crucière C; Rémond M
Arch Virol; 2004 Feb; 149(2):365-77. PubMed ID: 14745601
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
[TBL] [Abstract][Full Text] [Related]
8. Foot-and-mouth disease virus lacking the VP1 G-H loop: the mutant spectrum uncovers interactions among antigenic sites for fitness gain.
Baranowski E; Ruiz-Jarabo CM; Lim F; Domingo E
Virology; 2001 Sep; 288(2):192-202. PubMed ID: 11601891
[TBL] [Abstract][Full Text] [Related]
9. Cyclic peptides as conformationally restricted models of viral antigens: application to foot-and-mouth disease virus.
Valero ML; Camarero JA; Adeva A; Verdaguer N; Fita I; Mateu MG; Domingo E; Giralt E; Andreu D
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):133-40. PubMed ID: 9346844
[TBL] [Abstract][Full Text] [Related]
10. Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease.
Harmsen MM; van Solt CB; Fijten HP; van Keulen L; Rosalia RA; Weerdmeester K; Cornelissen AH; De Bruin MG; Eblé PL; Dekker A
Vet Microbiol; 2007 Mar; 120(3-4):193-206. PubMed ID: 17127019
[TBL] [Abstract][Full Text] [Related]
11. The potential of retro-inverso peptides as synthetic vaccines.
Van Regenmortel MH; Guichard G; Benkirane N; Briand JP; Muller S; Brown F
Dev Biol Stand; 1998; 92():139-43. PubMed ID: 9554267
[TBL] [Abstract][Full Text] [Related]
12. Serotype-independent detection of foot-and-mouth disease virus.
Muller JD; McEachern JA; Bossart KN; Hansson E; Yu M; Clavijo A; Hammond JM; Wang LF
J Virol Methods; 2008 Jul; 151(1):146-53. PubMed ID: 18440078
[TBL] [Abstract][Full Text] [Related]
13. [Antigenic structure of the foot-and-mouth virus. V. Protection of naturally susceptible animals from foot-and-mouth disease using a synthetic peptide].
Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Driagalin NN; Ivaniushchenkov VM
Bioorg Khim; 1989 Oct; 15(10):1313-7. PubMed ID: 2561049
[TBL] [Abstract][Full Text] [Related]
14. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus.
Mateu MG; Andreu D; Domingo E
Virology; 1995 Jun; 210(1):120-7. PubMed ID: 7793064
[TBL] [Abstract][Full Text] [Related]
15. Identification of a major antibody binding epitope in the non-structural protein 3D of foot-and-mouth disease virus in cattle and the development of a monoclonal antibody with diagnostic applications.
Yang M; Clavijo A; Li M; Hole K; Holland H; Wang H; Deng MY
J Immunol Methods; 2007 Apr; 321(1-2):174-81. PubMed ID: 17320098
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus.
Yang M; Clavijo A; Suarez-Banmann R; Avalo R
Vet Immunol Immunopathol; 2007 Jan; 115(1-2):126-34. PubMed ID: 17109972
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
[TBL] [Abstract][Full Text] [Related]
19. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
